rs5030730
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004006.3(DMD):c.3940C>T(p.Arg1314*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004006.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMD | ENST00000357033.9 | c.3940C>T | p.Arg1314* | stop_gained | Exon 29 of 79 | 1 | NM_004006.3 | ENSP00000354923.3 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:6
- -
The variant creates a premature nonsense codon, and is therefore predicted to significantly disrupt the protein structure. Found in at least one symptomatic patient, and not found in general population data. -
- -
- -
Nonsense variant predicted to result in protein truncation or nonsense mediated decay, and other loss-of-function variants have been reported downstream in HGMD; Published functional studies demonstrate that alternative splicing leads to different transcripts, some of which include exon skipping that bypasses the nonsense variant and correlates with a less severe phenotype (PMID: 11039581, 17041906); Not observed at significant frequency in large population cohorts (gnomAD); Based on the understanding of this genetic alteration, it may be amenable to nonsense read-through therapy that is currently available or in clinical trial; This variant is associated with the following publications: (PMID: 28116794, 17041906, 25525159, 16770791, 19959795, 25972034, 29604111, 28859693, 25612904, 28597072, 21972111, 29641567, 29581631, 35653365, 30833962, 11039581) -
- -
Duchenne muscular dystrophy Pathogenic:2
- -
This sequence change creates a premature translational stop signal (p.Arg1314*) in the DMD gene. RNA analysis indicates that this premature translational stop signal induces altered splicing and likely results in a shortened protein product. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with Becker muscular dystrophy (PMID: 11039581, 17041906, 19959795, 24292997, 29581631). ClinVar contains an entry for this variant (Variation ID: 11283). Studies have shown that this premature translational stop signal results in skipping of exon 29, but is expected to preserve the integrity of the reading-frame (PMID: 11039581, 17041906, 24292997). For these reasons, this variant has been classified as Pathogenic. -
Qualitative or quantitative defects of dystrophin Pathogenic:1
Variant summary: DMD c.3940C>T (p.Arg1314X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Variants downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 182875 control chromosomes (gnomAD). c.3940C>T has been reported in the literature in multiple hemizygous males affected with Becker Muscular Dystrophy, dilated cardiomyopathy, and elevated serum creatine kinase levels (e.g., Franz_2000, Ginjaar_2000, Deburgrave_2007, Torella_2010), and the variant has been shown to segregate with disease in related individuals. These data indicate that the variant is very likely to be associated with disease. Several publications report experimental evidence evaluating an impact on protein, finding that alternative exon skipping restored the open reading frame in a portion of transcripts in patient tissue, however, the level of exon skipping varied across tissues and between patients, correlating with disease severity and phenotypic outcomes (e.g., Franz_2000, Ginjaar_2000, Deburgrave_2007). The following publications have been ascertained in the context of this evaluation (PMID: 17041906, 10832829, 11039581, 19959795). Five submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
Becker muscular dystrophy Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at